In addition to allergies, COVID-19, RSV, influenza and a new Cicada COVID variant are on the rise. But which one do you have?

Flu and Covid, including a new variant called BA.3.2, nicknamed “cicada,” are still circulating across the U.S. in 2026. How ...

State health officials extend RSV vaccination season as 48 U.S. jurisdictions prolong immunization amid late RSV peak in 2024 ...

Vaccination rates against respiratory syncytial virus, or RSV, remain low among older adults. Improving access to vaccination ...

Add Yahoo as a preferred source to see more of our stories on Google. Respiratory Syncytial Virus or RSV is one of the most common respiratory viruses circulating today. Often thought of as only being ...

Add Yahoo as a preferred source to see more of our stories on Google. The season of never-ending sneezing and stuffy noses is underway, sending Americans to pharmacy lines in hopes of keeping illness ...

An analysis of adults hospitalized with either infection finds the adjusted mean hospitalization costs were $20,188 for hMPV ...

The antibody shots are about 80% effective at preventing babies from ending up in intensive care because of RSV. The ...

FDA has expanded approval of Arexvy (RSV vaccine, adjuvanted) to include prevention of LRTD caused by RSV in at-risk adults aged 18 to 49.

Cases of HMPV are skyrocketing across the U.S. The respiratory virus causes symptoms such as cough, fever, nasal congestion, ...

An additional three million people in England are now eligible for the NHS respiratory syncytial virus (RSV) vaccine ...

Pfizer Inc.’s vaccine to protect against a potentially dangerous respiratory infection will be offered to about three million ...